Trials / Terminated
TerminatedNCT06026332
ADSTILADRIN Early Utilization and Outcomes in the Real World Setting
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 202 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Multi-center, prospective non-interventional study to collect data on the early use of Adstiladrin in the US and Israel. Data will be collected from patients and prescribing physicians in a real-world setting
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ADSTILADRIN | Non-interventional |
Timeline
- Start date
- 2023-09-15
- Primary completion
- 2026-01-15
- Completion
- 2026-01-15
- First posted
- 2023-09-07
- Last updated
- 2026-02-17
Locations
31 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06026332. Inclusion in this directory is not an endorsement.